NEW YORK, Nov. 12, 2025 ( GLOBE NEWSWIRE ) -- LB Pharmaceuticals Inc ( &#34;LB Pharmaceuticals&#34; or the &#34;Company&#34; ) ( Nasdaq: LBRX ) today announced that it has granted to James Rawls, the new Senior Vice President of Regulatory Affairs of LB Pharmaceuticals, an equity award outside of, but subject ...

LBRX

<p>纽约，2025 年 11 月 12 日（GLOBE NEWSWIRE）-- LB Pharmaceuticals Inc（“LB Pharmaceuticals” 或 “公司”）（纳斯达克：LBRX）今天宣布，已向 LB Pharmaceuticals 的新任监管事务高级副总裁 James Rawls 授予了一项股权奖励，该奖励不在</p>

LB Pharmaceuticals 根据纳斯达克上市规则 5635(c)(4) 向新员工授予了激励股权